Physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease

Journal of Physiotherapy

Volumn 60, Issue 4, 2014, Pages 181-188

  Holland, Anne E ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Disease exacerbation; Physiotherapy; Rehabilitation

Indexed keywords

EID: 84913585216     PISSN: 18369553     EISSN: 18369561     Source Type: Journal    
DOI: 10.1016/j.jphys.2014.08.018     Document Type: Article

References (87)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org/. Accessed 21st August 2014.
2. Miravitlles M., Ferrer M., Pont A., Zalacain R., Alvarez-Sala J., Masa F., et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004, 59(5):387-395.
3. Costi S., Brooks D., Goldstein R.S. Perspectives that influence action plans for chronic obstructive pulmonary disease. Can Respir J 2006, 13(7):362-368.
4. Wilkinson T.M., Donaldson G.C., Hurst J.R., Seemungal T.A., Wedzicha J.A. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 169(12):1298-1303.
5. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164(9):1618-1623.
6. Mallia P., Footitt J., Sotero R., Jepson A., Contoli M., Trujillo-Torralbo M.B., et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186(11):1117-1124.
7. Hurst J.R., Donaldson G.C., Quint J.K., Goldring J.J., Baghai-Ravary R., Wedzicha J.A. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 179(5):369374.
8. Hurst J.R., Vestbo J., Anzueto A., Locantore N., Müllerova H., Tal-Singer R., et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363(12):1128-1138.
9. Roca M., Verduri A., Corbetta L., Clini E., Fabbri L.M., Beghe B. Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease. Eur J Clin Invest 2013, 43(5):510-521.
10. Wedzicha J.A., Seemungal T.A., MacCallum P.K., Paul E.A., Donaldson G.C., Bhowmik A., et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thrombos Haemost 2000, 84(2):210-215.
11. Donaldson G.C., Hurst J.R., Smith C.J., Hubbard R.B., Wedzicha J.A. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010, 137(5):1091-1097.
12. Spruit M.A., Gosselink R., Troosters T., Kasran A., Gayan-Ramirez G., Bogaerts P., et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003, 58(9):752-756.
13. Pitta F., Troosters T., Probst V.S., Spruit M.A., Decramer M., Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006, 129(3):536-544.
14. Decramer M., Acquet L.M., Fagard R., Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994, 150:11-16.
15. Crul T., Spruit M.A., Gayan-Ramirez G., Quarck R., Gosselink R., et al. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest 2007, 37(11):897-904.
16. Borges R.C., Carvalho C.R. Physical activity in daily life in Brazilian COPD patients during and after exacerbation. COPD 2012, 9(6):596-602.
17. Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57(10):847-852.
18. Hoogendoorn M., Feenstra T.L., Hoogenveen R.T., Al M., Molken M.R. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis 2010, 5:435-444.
19. Soler-Cataluna J.J., Martinez-Garcia M.A., Roman Sanchez P., Salcedo E., Navarro M., Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60(11):925-931.
20. Hopkinson N.S., Tennant R.C., Dayer M.J., Swallow E.B., Hansel T.T., Moxham J., et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007, 8:25.
21. Alahmari A.D., Patel A.R., Kowlessar B.S., Mackay A.J., Singh R., Wedzicha J.A., et al. Daily activity during stability and exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med 2014, 14(1):98.
22. Garcia-Aymerich J., Farrero E., Felez M.A., Izquierdo J., Marrades R.M., Anto J.M. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003, 58(2):100-105.
23. Waschki B., Kirsten A., Holz O., Müller K.C., Meyer T., Watz H., et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011, 140(2):331-342.
24. Hilleman D.E., Dewan N., Malesker M., Friedman M., Pharmacoeconomic evaluation of COPD.2000 Chest 2009, 136(5 Suppl):e30.
25. Australian Institute of Health and Welfare. Australia's Health 2010. Australia's health no. 12. Cat. no. AUS 122. 2010; Retrieved from http://www.aihw.gov.au/publication-detail/?id=6442468376&tab=2. Accessed 17th February 2013.
26. National Institute for Health and Clinical Excellence (NICE). Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010.
27. Guarascio A.J., Ray S.M., Finch C.K., Self T.H. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics and outcomes research: CEOR 2013, 5:235-245.
28. Punekar Y.S., Shukla A., Mullerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis 2014, 9:65-73.
29. Walters J.A., Gibson P.G., Wood-Baker R., Hannay M., Walters E.H. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009, (1):CD001288.
30. Vollenweider D.J., Jarrett H., Steurer-Stey C.A., Garcia-Aymerich J., Puhan M.A. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012, 12:CD010257.
31. Austin M.A., Wills K.E., Blizzard L., Walters E.H., Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ 2010, 341:c5462.
32. Ram F.S., Picot J., Lightowler J., Wedzicha J.A. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004, (1):CD004104.
33. Bott J., Blumenthal S., Buxton M., Ellum S., Falconer C., Garrod R., et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 2009, 64(Suppl 1):i1-i51.
34. Menadue C., Alison J.A., Piper A.J., Flunt D., Ellis E.R. Bilevel ventilation during exercise in acute on chronic respiratory failure: a preliminary study. Respir Med 2010, 104(2):219-227.
35. Holland A.E., Hill C.J., Jones A.Y., McDonald C.F. Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012, 10:CD008250.
36. Valenza M.C., Valenza-Pena G., Torres-Sanchez I., Gonzalez-Jimenez E., Conde-Valero A., Valenza-Demet G. Effectiveness of controlled breathing techniques on anxiety and depression in hospitalized patients with COPD: a randomized clinical Trial. Respir Care 2014, 59(2):209-215.
37. Zakerimoghadam M., Tavasoli K., Nejad A.K., Khoshkesht S. The effect of breathing exercises on the fatigue levels of patients with chronic obstructive pulmonary disease. Acta Medica Indonesiana 2011, 43(1):29-33.
38. Gosselink R.A., Wagenaar R.C., Rijswijk H., Sargeant A.J., Decramer M.L. Diaphragmatic breathing reduces efficiency of breathing in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995, 151:1136-1142.
39. Vitacca M., Clini E., Bianchi L., Ambrosino N. Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency. Eur Respir J. 1998, 11:408-415.
40. Holland A.E., Button B.M. Is there a role for airway clearance techniques in chronic obstructive pulmonary disease?. Chron Respir Dis 2006, 3(2):83-91.
41. Osadnik C.R., McDonald C.F., Holland A.E. Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis. 2014, 9:301-302.
42. Osadnik C.R., McDonald C.F., Holland A.E. Airway clearance techniques in acute exacerbations of COPD: a survey of Australian physiotherapy practice. Physiotherapy 2013, 99(2):101-106.
43. Osadnik C.R., McDonald C.F., Jones A.P., Holland A.E. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012, 3:CD008328.
44. Cross J., Elender F., Barton G., Clark A., Shepstone L., Blyth A., et al. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX). Health Technol Assess 2010, 14(23):1-147. iii-iv.
45. Newton D.A., Stephenson A. Effect of physiotherapy on pulmonary function. A laboratory study. Lancet 1978, 2(8083):228-229.
46. Bellone A., Spagnolatti L., Massobrio M., Bellei E., Vinciguerra R., Barbieri A., et al. Short-term effects of expiration under positive pressure in patients with acute exacerbation of chronic obstructive pulmonary disease and mild acidosis requiring non-invasive positive pressure ventilation. Intensive Care Med 2002, 28:581-585.
47. Inal-Ince D., Savci S., Topeli A., Arikan H. Active cycle of breathing techniques in non-invasive ventilation for acute hypercapnic respiratory failure. Aust J Physiother 2004, 50:67-73.
48. Vargas F., Bui H.N., Boyer A., Salmi L.R., Gbikpi-Benissan G., Guenard H., et al. Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial. Crit Care 2005, 9:R382-R389.
49. Osadnik C.R., McDonald C.F., Miller B.R., Hill C.J., Tarrant B., Steward R., et al. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial. Thorax 2014, 69(2):137-143.
50. de Morton N.A., Keating J.L., Jeffs K. Exercise for acutely hospitalised older medical patients. Cochrane Database Syst Rev 2007, (1):CD005955.
51. Tang C.Y., Blackstock F.C., Clarence M., Taylor N.F. Early rehabilitation exercise program for inpatients during an acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. J Cardiopulm Rehabil Prevent 2012, 32(3):163-169.
52. Troosters T., Probst V.S., Crul T., Pitta F., Gayan-Ramirez G., Decramer M., et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181(10):1072-1077.
53. Puhan M., Scharplatz M., Troosters T., Walters E.H., Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009, (1):CD005305.
54. Greening N.J., Williams J.E., Hussain S.F., arvey-Dunstan T.C., Bankart M.J., Chaplin E.J., et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ 2014, 349:g4315.
55. Behnke M., Taube C., Kirsten D., Lehnigk B., Jorres R.A., Magnussen H. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med 2000, 94(12):1184-1191.
56. Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit. Arch Phys Med Rehabil 1998, 79(7):849-854.
57. Eaton T., Young P., Fergusson W., Moodie L., Zeng I., O'Kane F., et al. Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirol 2009, 14(2):230-238.
58. Ko F.W.S., Dai D.L.K., Ngai J., Tung A., Ng S., Lai K., et al. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD. Respirol 2011, 16:617-624.
59. Man W.D.C., Polkey M.I., Donaldson N., Gray B.J., Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004, 329:1209-1213.
60. Troosters T., Gosselink R., De Paepe K., Decramer M. Pulmonary rehabilitation improves survival in COPD patients with a recent severe acute exacerbation. Am J Respir Crit Care Med 2002, 165:A16.
61. Murphy N., Bell C., Costello R.W. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir Med 2005, 99:1297-1302.
62. Seymour J.M., Moore L., Jolley C.J., Ward K., Creasey J., Steier J.S., et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax 2010, 65:423-428.
63. Jones S.E., Green S.A., Clark A.L., Dickson M.J., Nolan A.M., Moloney C., et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax 2014, 69(2):181-182.
64. Harrison SL, Robertson N, Apps L, M CS, Morgan MD, Singh SJ. 'We are not worthy' - understanding why patients decline pulmonary rehabilitation following an acute exacerbation of COPD. Diasbil Rehabil 2014:1-7.
65. Suissa S., Dell'Aniello S., Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012, 67(11):957-963.
66. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007, 357(14):1373-1381.
67. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356(8):775-789.
68. Tashkin D.P., Celli B., Senn S., Burkhart D., Kesten S., Menjoge S., et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359(15):1543-1554.
69. Calverley P.M., Rabe K.F., Goehring U.M., Kristiansen S., Fabbri L.M., Martinez F.J., et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009, 374(9691):685-694.
70. Laurin C., Moullec G., Bacon S.L., Lavoie K.L. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 2012, 185(9):918-923.
71. Zwerink M., Brusse-Keizer M., van der Valk P.D., Zielhuis G.A., Monninkhof E.M., van der Palen J., et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014, 3:CD002990.
72. Fan V.S., Gaziano J.M., Lew R., Bourbeau J., Adams S.G., Leatherman S., et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med 2012, 156(10):673-683.
73. Peytremann-Bridevaux I., Taffe P., Burnand B., Bridevaux P.O., Puhan M.A. Mortality of patients with COPD participating in chronic disease management programmes: a happy end?. Thorax 2014, 69(9):865-866.
74. Walters J.A., Turnock A.C., Walters E.H., Wood-Baker R. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010, (5):CD005074.
75. Trappenburg J.C., Monninkhof E.M., Bourbeau J., Troosters T., Schrijvers A.J., Verheij T.J., et al. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax 2011, 66(11):977-984.
76. Poole P., Black P.N., Cates C.J. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012, 8:CD001287.
77. Polisena J., Tran K., Cimon K., Hutton B., McGill S., Palmer K., et al. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare 2010, 16(3):120-127.
78. Pinnock H., Hanley J., McCloughan L., Todd A., Krishan A., Lewis S., et al. Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ 2013, 347:f6070.
79. Ringbaek T.J., Viskum K., Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?. Eur Respir J 2002, 20(1):38-42.
80. Is 12-hour oxygen as effective as 24-hour oxygen in advanced chronic obstructive pulmonary disease with hypoxemia? (The nocturnal oxygen therapy trial - NOTT). Chest 1980; 78(3):419-420.
81. Au D.H., Bryson C.L., Chien J.W., Sun H., Udris E.M., Evans L.E., et al. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009, 24(4):457-463.
82. Godtfredsen N.S., Vestbo J., Osler M., Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002, 57(11):967-972.
83. Kon S.S., Patel M.S., Canavan J.L., Clark A.L., Jones S.E., Nolan C.M., et al. Reliability and validity of 4-metre gait speed in COPD. Eur Respir J 2013, 42(2):333-340.
84. Jones S.E., Kon S.S., Canavan J.L., Patel M.S., Clark A.L., Nolan C.M., et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD. Thorax 2013, 68(11):1015-1020.
85. Ozalevli S., Ozden A., Itil O., Akkoclu A. Comparison of the Sit-to-Stand Test with 6min walk test in patients with chronic obstructive pulmonary disease. Respir Med 2007, 101(2):286-293.
86. Mesquita R., Janssen D.J., Wouters E.F., Schols J.M., Pitta F., Spruit M.A. Within-day test-retest reliability of the Timed Up & Go test in patients with advanced chronic organ failure. Arch Phys Med Rehabil 2013, 94(11):2131-2138.
87. Maltais F., Bourbeau J., Shapiro S., Lacasse Y., Perrault H., Baltzan M., et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2008, 149(12):869-878.